We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




AI Model Reveals True Biological Age From Five Drops of Blood

By LabMedica International staff writers
Posted on 19 Mar 2025
Print article
Image: A general diagram of the AI-powered biological age model (Photo courtesy of Zi Wang/Osaka University)
Image: A general diagram of the AI-powered biological age model (Photo courtesy of Zi Wang/Osaka University)

Some individuals seem to defy the effects of aging, appearing significantly younger than their peers despite sharing the same age. Aging isn't solely determined by the number of years we have lived; it's also influenced by genetics, lifestyle, and environmental factors. Conventional methods of assessing biological age typically focus on broad biomarkers, like DNA methylation or protein levels. However, these techniques often overlook the complex hormonal systems that regulate the body's internal balance. Now, scientists have developed a novel approach for estimating a person’s biological age, which measures how well the body has aged rather than simply counting the years since birth.

This new method, developed by scientists at Osaka University (Osaka, Japan), uses only five drops of blood to analyze 22 key steroids and their interactions, offering a more precise health assessment. Published in Science Advances, the team’s breakthrough study presents a potential leap forward in personalized health management, enabling earlier identification of age-related health risks and more tailored interventions. Since hormones are essential for maintaining bodily functions, the researchers chose to focus on these as key indicators of aging. To test this hypothesis, the team concentrated on steroid hormones, which are vital in metabolism, immune response, and stress management.

The researchers created a deep neural network (DNN) model that incorporates steroid metabolism pathways, making it the first AI model to consider the interactions between different steroid molecules. Rather than examining absolute steroid levels—which can vary greatly between individuals—the model looks at the ratios of steroids, delivering a more personalized and accurate biological age assessment. Trained on blood samples from hundreds of individuals, the model revealed that biological age differences become more pronounced as people age, an effect the researchers liken to a river widening as it flows downstream.

One of the most surprising findings of the study concerns cortisol, a steroid hormone linked to stress. The researchers discovered that when cortisol levels doubled, biological age increased by about 1.5 times. This suggests that chronic stress could speed up aging at the biochemical level, emphasizing the importance of managing stress to maintain long-term health. The team believes that this AI-driven biological age model could lead to more personalized health monitoring.

Potential future applications for this technology include early disease detection, tailored wellness programs, and lifestyle recommendations to slow the aging process. While the study marks significant progress, the team acknowledges that biological aging is influenced by numerous factors beyond hormones. With continued advancements in AI and biomedical research, the ability to measure—and possibly slow—biological aging is becoming more attainable. For now, the capability to assess an individual’s “aging speed” with a simple blood test could be a revolutionary development in preventive healthcare.

“This is just the beginning,” said Dr. Zi Wang, co-first and corresponding author of this work. “By expanding our dataset and incorporating additional biological markers, we hope to refine the model further and unlock deeper insights into the mechanisms of aging.”

Related Links:
Osaka University

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
New
H.pylori Test
Humasis H.pylori Card

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.